Veninga C C, Lundborg C S, Lagerløv P, Hummers-Pradier E, Denig P, Haaijer-Ruskamp F M
Northern Centre for Healthcare Research, University of Groningen, The Netherlands.
Ann Pharmacother. 2000 Jan;34(1):19-26. doi: 10.1345/aph.19068.
To evaluate adherence of general practitioners to treatment guidelines regarding urinary tract infections in three European countries and to investigate whether differences in adherence at the prescribing level within and between countries could be explained by general practitioners' knowledge and attitudes, characteristics, or national setting.
Prescribing data collected in 1994-1995 were analyzed regarding use of first-choice drugs and duration of treatment, knowledge and attitudes were assessed with a questionnaire, and multiple regression analysis was used to explain differences in prescribing behavior within and between countries.
Our study is based on data from 85.6% of the 584 general practitioners who were scheduled to participate in a continuing education program. The mean proportion of responses in agreement with the guidelines regarding first-choice drugs was 0.69 in Sweden, 0.78 in the Netherlands, and 0.79 in Norway; regarding duration of treatment, the mean proportion was 0.56 in Sweden, 0.67 in the Netherlands, and 0.59 in Norway. The proportion of first-choice drugs prescribed for women (18-75 y) was 0.55 in Sweden, 0.83 in the Netherlands, and 1.00 in Norway (patients >16 y). The duration of treatment was 7.6 defined daily doses per prescription in Sweden, 5.9 in the Netherlands, and 6.6 in Norway. Knowledge and attitudes explained 0-17% of the variation in prescribing. Years in practice explained 0-11%, and the general practitioners' gender had no explanatory value. The national setting explained most of the variation between countries.
Differences in prescribing behavior can be explained only to a small extent by deviations from the guidelines in terms of knowledge and attitudes. Between countries, differences in regulation, marketing, and distribution of drugs seem to be of much greater importance.
评估欧洲三个国家的全科医生对尿路感染治疗指南的遵循情况,并调查国家内部和国家之间在处方层面的遵循差异是否可以通过全科医生的知识和态度、特征或国家背景来解释。
分析1994 - 1995年收集的关于首选药物使用和治疗时长的处方数据,通过问卷调查评估知识和态度,并使用多元回归分析来解释国家内部和国家之间处方行为的差异。
我们的研究基于计划参加继续教育项目的584名全科医生中85.6%的数据。在瑞典,与首选药物指南一致的回答的平均比例为0.69,荷兰为0.78,挪威为0.79;关于治疗时长,瑞典的平均比例为0.56,荷兰为0.67,挪威为0.59。为18 - 75岁女性开具的首选药物比例在瑞典为0.55,荷兰为0.83,挪威为1.00(患者年龄>16岁)。瑞典每张处方的治疗时长为7.6限定日剂量,荷兰为5.9,挪威为6.6。知识和态度解释了处方差异的0 - 17%。从业年限解释了0 - 11%,全科医生的性别没有解释价值。国家背景解释了国家之间的大部分差异。
处方行为的差异在知识和态度方面偏离指南的程度上只能得到很小程度的解释。在国家之间,药物监管、营销和分销方面的差异似乎更为重要。